Annual Accounts Receivable
$15.22 M
-$12.99 M-46.04%
December 31, 2023
Summary
- As of February 8, 2025, DERM annual accounts receivable is $15.22 million, with the most recent change of -$12.99 million (-46.04%) on December 31, 2023.
- During the last 3 years, DERM annual accounts receivable has fallen by -$8.71 million (-36.38%).
- DERM annual accounts receivable is now -46.04% below its all-time high of $28.21 million, reached on December 31, 2022.
Performance
DERM Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$10.67 M
+$206.00 K+1.97%
September 30, 2024
Summary
- As of February 8, 2025, DERM quarterly accounts receivable is $10.67 million, with the most recent change of +$206.00 thousand (+1.97%) on September 30, 2024.
- Over the past year, DERM quarterly accounts receivable has dropped by -$4.55 million (-29.90%).
- DERM quarterly accounts receivable is now -66.38% below its all-time high of $31.74 million, reached on September 30, 2021.
Performance
DERM Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
DERM Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.0% | -29.9% |
| 3 y3 years | -36.4% | -53.8% |
| 5 y5 years | +165.9% | -55.4% |
DERM Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.0% | at low | -65.8% | +33.6% |
| 5 y | 5-year | -46.0% | at low | -66.4% | +33.6% |
| alltime | all time | -46.0% | -100.0% | -66.4% | +33.6% |
Journey Medical Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.67 M(+2.0%) |
| Jun 2024 | - | $10.46 M(+6.8%) |
| Mar 2024 | - | $9.80 M(-35.6%) |
| Dec 2023 | $15.22 M(-46.0%) | $15.22 M(+90.5%) |
| Sep 2023 | - | $7.99 M(-52.3%) |
| Jun 2023 | - | $16.74 M(-39.4%) |
| Mar 2023 | - | $27.62 M(-2.1%) |
| Dec 2022 | $28.21 M(+22.0%) | $28.21 M(-1.1%) |
| Sep 2022 | - | $28.53 M(-0.5%) |
| Jun 2022 | - | $28.67 M(-8.1%) |
| Mar 2022 | - | $31.18 M(+34.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $23.11 M(-3.4%) | $23.11 M(-27.2%) |
| Sep 2021 | - | $31.74 M(+21.2%) |
| Jun 2021 | - | $26.19 M(+9.5%) |
| Dec 2020 | $23.93 M(+26.2%) | $23.93 M |
| Dec 2019 | $18.95 M(+231.1%) | - |
| Dec 2018 | $5.72 M(>+9900.0%) | - |
| Dec 2017 | $52.00 K(-99.8%) | - |
| Dec 2016 | $21.40 M(>+9900.0%) | - |
| Dec 2015 | $0.00(-100.0%) | - |
| Dec 2014 | $7.30 M(>+9900.0%) | - |
| Dec 2013 | $0.00 | - |
FAQ
- What is Journey Medical annual accounts receivable?
- What is the all time high annual accounts receivable for Journey Medical?
- What is Journey Medical annual accounts receivable year-on-year change?
- What is Journey Medical quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Journey Medical?
- What is Journey Medical quarterly accounts receivable year-on-year change?
What is Journey Medical annual accounts receivable?
The current annual accounts receivable of DERM is $15.22 M
What is the all time high annual accounts receivable for Journey Medical?
Journey Medical all-time high annual accounts receivable is $28.21 M
What is Journey Medical annual accounts receivable year-on-year change?
Over the past year, DERM annual accounts receivable has changed by -$12.99 M (-46.04%)
What is Journey Medical quarterly accounts receivable?
The current quarterly accounts receivable of DERM is $10.67 M
What is the all time high quarterly accounts receivable for Journey Medical?
Journey Medical all-time high quarterly accounts receivable is $31.74 M
What is Journey Medical quarterly accounts receivable year-on-year change?
Over the past year, DERM quarterly accounts receivable has changed by -$4.55 M (-29.90%)